MedPath
NMPA Approval

Ibuprofen Suspension

国药准字H20243047

January 9, 2024

Drug Information

布洛芬混悬液

口服混悬剂

100毫升: 2克

化学药品

January 9, 2024

Company Information

Applicant Company

南宁市防城港路10号

Manufacturing Company

南宁市防城港路10号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

布洛芬混悬液 - NMPA 批准文号 | MedPath